Evidence map›Paper›PMID 26313919›Full record

ArticleCell death & disease2015

Transglutaminase 2--a novel inhibitor of adipogenesis.

V D Myneni, G Melino, M T Kaartinen

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in nutrition · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Cystamine reduces vascular stiffness in Western diet-fed female mice.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  12. Review
  13. Article
  14. Article
  15. Transglutaminases and Obesity in Humans: Association ofInternational journal of molecular sciences · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

V D MyneniFaculty of Dentistry, McGill University, Montreal, QC, Canada.
G MelinoDepartment Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy.
M T KaartinenFaculty of Dentistry, McGill University, Montreal, QC, Canada.
McGill University · CAUniversity of Rome Tor Vergata · IT

Funding

CIHRMedical Research Council MC_U132670600
6 · The paper itself

Abstract

Differentiation of preadipocytes to lipid storing adipocytes involves extracellular signaling pathways, matrix remodeling and cytoskeletal changes. A number of factors have been implicated in maintaining the preadipocyte state and preventing their differentiation to adipocytes. We have previously reported that a multifunctional and protein crosslinking enzyme, transglutaminase 2 (TG2) is present in white adipose tissue. In this study, we have investigated TG2 function during adipocyte differentiation. We show that TG2 deficient mouse embryonic fibroblasts (Tgm2-/- MEFs) display increased and accelerated lipid accumulation due to increased expression of major adipogenic transcription factors, PPARγ and C/EBPα. Examination of Pref-1/Dlk1, an early negative regulator of adipogenesis, showed that the Pref-1/Dlk1 protein was completely absent in Tgm2-/- MEFs during early differentiation. Similarly, Tgm2-/- MEFs displayed defective canonical Wnt/β-catenin signaling with reduced β-catenin nuclear translocation. TG2 deficiency also resulted in reduced ROCK kinase activity, actin stress fiber formation and increased Akt phosphorylation in MEFs, but did not alter fibronectin matrix levels or solubility. TG2 protein levels were unaltered during adipogenic differentiation, and was found predominantly in the extracellular compartment of MEFs and mouse WAT. Addition of exogenous TG2 to Tgm2+/+ and Tgm2-/- MEFs significantly inhibited lipid accumulation, reduced expression of PPARγ and C/EBPα, promoted the nuclear accumulation of β-catenin, and recovered Pref-1/Dlk1 protein levels. Our study identifies TG2 as a novel negative regulator of adipogenesis.

Indexed as

ActinsAdipocytesAdipogenesisAdipose Tissue, WhiteAnimalsbeta CateninCalcium-Binding ProteinsCCAAT-Enhancer-Binding ProteinsCell DifferentiationEmbryo, MammalianFibroblastsGene Expression RegulationGTP-Binding ProteinsIntercellular Signaling Peptides and ProteinsMiceMice, KnockoutActinsbeta CateninCalcium-Binding ProteinsCCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseCTNNB1 protein, mouseDlk1 protein, mouseGTP-Binding ProteinsIntercellular Signaling Peptides and ProteinsPPAR gammaProtein Glutamine gamma Glutamyltransferase 2Proto-Oncogene Proteins c-aktrho-Associated KinasesTransglutaminases

Identifiers

PMID26313919
PMCPMC4558519
OpenAlexW1928145000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.